Abingdon Health Plc (AIM:ABDX)
London
· Delayed Price · Currency is GBP · Price in GBX 7.50
-0.01 (-0.15%)
Feb 21, 2025, 4:35 PM GMT+1
Abingdon Health Revenue
In the fiscal year ending June 30, 2024, Abingdon Health had annual revenue of 6.14M GBP with 51.67% growth. Abingdon Health had revenue of 3.73M in the half year ending June 30, 2024, with 229.35% growth.
Revenue
6.14M
Revenue Growth
+51.67%
P/S Ratio
3.73
Revenue / Employee
73.04K
Employees
84
Market Cap
28.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 6.14M | 2.09M | 51.67% |
| Jun 30, 2023 | 4.05M | 1.21M | 42.68% |
| Jun 30, 2022 | 2.84M | -8.78M | -75.60% |
| Jun 30, 2021 | 11.62M | 6.38M | 121.93% |
| Jun 30, 2020 | 5.24M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| Hikma Pharmaceuticals | 2.39B |
| ConvaTec Group | 1.74B |
| HUTCHMED (China) | 483.31M |
| Genus | 668.80M |
Abingdon Health News
- 26 days ago - AIM Market Roundup: Good Energy, Beacon Energy, Abingdon Health - The Armchair Trader
- 2 months ago - Small Cap Stocks: Hummingbird, LPA Group, Cadence Minerals - The Armchair Trader